Sports Ventures Acquisition (AKIC) 10-Q 15 Nov 21 2021 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Document Information Line Items
Entity Registrant Name	Sports Ventures Acquisition Corp.
Trading Symbol	AKIC
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001826574
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39842
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	9705 Collins Ave
Entity Address, Address Line Two	1901N
Entity Address, City or Town	Bal Harbour
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33154
City Area Code	(786)
Local Phone Number	650-0074
Title of 12(b) Security	Class A Ordinary Shares, par value $0.0001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Class A Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		23,660,000
Class B Ordinary Shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		5,750,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Assets
Cash	$ 575,714
Deferred offering costs		154,103
Prepaid expenses and other current assets	400,639
Total current assets	976,353
Other assets	101,084
Investments held in Trust Account	230,021,717
Total Assets	231,099,154	154,103
Current liabilities:
Accounts payable and offering costs	43,610	114,697
Due to related parties	92,653	21,666
Total current liabilities	136,263	136,363
Warrant liability	4,670,007
Deferred underwriting discount	8,050,000
Total liabilities	12,856,270	136,363
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, 23,000,000 and 0 shares subject to possible redemption at redemption value at September 30, 2021 and December 31, 2020, respectively	230,000,000
Shareholders’ Equity (Deficit):
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, 660,000 and 0 shares outstanding at September 30, 2021 and December 31, 2020 (excluding the 23,000,000 shares subject to possible redemption)	66
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively	575	575
Additional paid-in capital		24,425
Accumulated deficit	(11,757,757)	(7,260)
Total shareholders’ equity (deficit)	(11,757,116)	17,740
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)	$ 231,099,154	$ 154,103

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	5,000,000	5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares, redemption shares	23,000,000	0
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	500,000,000	500,000,000
Ordinary shares, shares outstanding	660,000	0
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	50,000,000	50,000,000
Ordinary shares, shares outstanding	5,750,000	5,750,000
Ordinary shares, shares issued	5,750,000	5,750,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Operating costs	$ 199,705	$ 642,623
Loss from operations	(199,705)	(642,623)
Other income (expense):
Interest earned on cash and investments held in Trust Account	2,959	21,717
Offering costs allocated to warrant liabilities		(658,002)
Change in fair value of warrant liabilities	3,139,113	7,240,329
Total other income	3,142,072	6,604,044
Net income	$ 2,942,367	$ 5,961,421
Class A Ordinary Shares
Other income (expense):
Basic and diluted weighted average shares outstanding (in Shares)	23,660,000	23,053,333
Basic and diluted net income per share (in Dollars per share)	$ 0.1	$ 0.21
Class B Ordinary Shares
Other income (expense):
Basic and diluted weighted average shares outstanding (in Shares)	5,750,000	5,730,769
Basic and diluted net income per share (in Dollars per share)	$ 0.1	$ 0.21

Condensed Consolidated Statemen

Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)	Class AOrdinary Shares	Class BOrdinary Shares	Additional Paid-in-Capital	Retained Earnings (Accumulate Deficit)	Total
Balance at Dec. 31, 2020		$ 575	$ 24,425	$ (7,260)	$ 17,740
Balance (in Shares) at Dec. 31, 2020		5,750,000
Sale of 660,000 Private Placement Warrants on January 8, 2021	$ 66		6,267,372		$ 6,267,438
Sale of 660,000 Private Placement Warrants on January 8, 2021 (in Shares)	660,000				660,000
Accretion of Class A ordinary shares subject to redemption			(6,291,797)	(17,711,918)	$ (24,003,715)
Net income (loss)				(893,358)	(893,358)
Balance at Jun. 30, 2021	$ 66	$ 575		(147,001,249)	(14,699,483)
Balance (in Shares) at Jun. 30, 2021	660,000	5,750,000
Net income (loss)				2,942,367	2,942,367
Balance at Sep. 30, 2021	$ 66	$ 575		$ (11,757,757)	$ (11,757,116)
Balance (in Shares) at Sep. 30, 2021	660,000	5,750,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) (Parentheticals)	6 Months Ended
	Jun. 30, 2021shares
Statement of Stockholders' Equity [Abstract]
Sale of shares in private placement	660,000

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows (Unaudited)	9 Months Ended
	Sep. 30, 2021USD ($)
Cash flows from operating activities:
Net income	$ 5,961,421
Adjustments to reconcile net income to net cash used in operating activities:
Formation costs paid by sponsor
Interest earned on cash and investments held in Trust Account	(21,717)
Change in fair value of warrant liabilities	(7,240,329)
Offering costs allocated to warrant liabilities	658,002
Changes in operating assets and liabilities:
Prepaid expenses	(501,723)
Accounts payable and accrued expenses	83,016
Net cash used in operating activities	(1,061,330)
Cash Flows from Investing Activities:
Cash invested in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting commissions	229,566,057
Proceeds from issuance of Private Placement Units	6,600,000
Borrowings from related party	101,855
Payment of borrowings from related party	(9,202)
Proceeds from note payable-related party	182,457
Payment of note payable-related party	(204,123)
Payment of underwriter discount	(4,600,000)
Net cash provided by financing activities	231,637,044
Net change in cash	575,714
Cash, beginning of period
Cash, end of the period	575,714
Supplemental disclosure of cash flow information:
Deferred underwriting commissions payable charged to additional paid-in capital	$ 8,050,000

Organization and Business Opera

Organization and Business Operations	9 Months Ended
	Sep. 30, 2021
Organization and Business Operations [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Organization and General Sports Ventures Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on September 24, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to the Business Combination. All activity for the period from September 24, 2020 through September 30, 2020 was not significant. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2021, the Company had not commenced any operations. All activity for the period from September 24, 2020 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering (“IPO”), which is described below and since the IPO, searching for a target to complete its Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments in the Company’s Trust account and will recognize changes in the fair value of the warrant liability as other income (expense). The Company’s sponsor is AKICV LLC, a Delaware limited liability company (the “Sponsor”). Financing The registration statement for the Company’s IPO was declared effective January 5, 2021 (the “Effective Date”). On January 8, 2021, the Company consummated its IPO of 23,000,000 units (“Units”), including 3,000,000 Units issued pursuant to the full exercise of the underwriters’ over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share, and one-third of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”), with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Simultaneously with the closing of the IPO, pursuant to the Unit Subscription Agreement, the Company completed the private sale of 660,000 Units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Units, generating gross proceeds to the Company of $6,600,000. The Private Placement Units include 220,000 warrants to purchase an aggregate of 220,000 Class A ordinary shares of the Company (the “Private Placement Warrants”). The Private Placement Units are identical to the Units sold in the IPO, except as otherwise disclosed in Note 5. No underwriting discounts or commissions were paid with respect to such sale. Each Unit consists of one share of Class A ordinary shares, and one-third redeemable warrant to purchase one share of Class A ordinary shares at a price of $11.50 per whole share, generating gross proceeds of $6,600,000, which is described in Note 4. Offering costs of the IPO amounted to $13,083,943 of which $658,022 were allocated to the warrant liabilities and expensed immediately and $12,425,941 were charged to temporary equity upon completion of the IPO and the exercise of the over-allotment option. Trust Account Following the closing of the IPO on January 8, 2021, $230,000,000 (approximately $10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), the proceeds from this IPO and the Private Placement Units will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation and (iii) the redemption of all of its public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of this IPO, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public shareholders. Initial Business Combination The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (net of taxes payable) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will have until January 8, 2023 to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate. The Company’s Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (i) to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete its initial Business Combination by January 8, 2023 (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame). The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third-party (other than the Company’s independent auditors) for services rendered or products sold to us, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (i) $10.00 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, The Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. We have not asked the Sponsor to reserve for such obligations. Liquidity and Capital Resources As of September 30, 2021, the Company had cash outside the Trust Account of $575,714 available for working capital needs. All remaining investments held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination, and is restricted for use either in a Business Combination, pay tax obligations or to redeem ordinary shares. As of September 30, 2021, none of the investments in the Trust Account was available to be withdrawn as described above. In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). The Company anticipates that the $575,714 outside of the Trust Account as of September 30, 2021, will be sufficient to allow the Company to operate for at least the next 12 months from the issuance of these financial statements, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 6) from the shareholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 6), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth due diligence and negotiating the Business Combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the Business Combination. Moreover, the Company will need to raise additional capital through loans from its Sponsor, officers, directors, or third parties. None of the Sponsor, officers or directors are under any obligation to advance funds to, or to invest in, the Company. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of its business plan, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

Revision of Previously Issued F

Revision of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2021
Revision Of Previously Issued Financial Statements [Abstract]
Revision of Previously Issued Financial Statements	Note 2 — Revision of Previously Issued Financial Statements In the Company’s previously issued financial statements, a portion of the public shares were classified as permanent equity to maintain shareholders’ equity greater than $5,000,000 on the basis that the Company will consummate its initial Business Combination only if the Company has net tangible assets of at least $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. Management re-evaluated the Company’s application of Accounting Standards Codification (“ASC”) 480-10-99 to its accounting classification of public shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible asset required by the Company to complete its initial Business Combination. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements;” the Company evaluated the changes and has determined that the related impacts were not material to its previously issued financial statements. Therefore, management, in consultation with the Audit Committee, concluded that the Company’s previously issued financial statements impacted should be revised to report all public shares as temporary equity. As such the Company is revising those periods in this Quarterly Report. In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company also revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case both classes of shares will share pro rata in the income and losses of the Company. There has been no change in the Company’s total assets, liabilities or operating results. The impact of the revision on the Company’s financial statements is reflected in the following table: As Previously Reported Revision Revised Balance Sheet as of January 8, 2021 Ordinary shares subject to possible redemption ($) $ 206,620,900 $ 23,379,100 $ 230,000,000 Class A ordinary shares, $0.0001 par value 300 (234 ) 66 Class B ordinary shares, $0.0001 par value 575 — 575 Additional Paid in Capital 5,669,811 (5,645,386 ) 24,425 Accumulated Deficit (670,682 ) (17,733,480 ) (18,404,162 ) Total Shareholders’ Equity (Deficit) $ 5,000,004 $ (23,379,100 ) $ (18,379,096 ) Number of shares subject to redemption 20,662,090 2,337,910 23,000,000

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus as filed with the SEC on January 7, 2021, which contains the audited financial statements and notes thereto. The interim results for the three and nine months ended September 30, 2021 and for the period September 24, 2020 through September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Investments Held in Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs amounted to $13,083,943 of which $658,022 were allocated to the warrant liabilities and expensed immediately and $12,425,941 were charged to temporary equity upon completion of the IPO and the exercise of the over-allotment option. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At September 30, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds from IPO $ 230,000,000 Less: Proceeds allocated to Public Warrants (11,577,774 ) Class A ordinary share issuance costs (12,425,941 ) Plus: Accretion of carrying value to redemption value 24,003,715 Contingently redeemable Class A ordinary shares $ 230,000,000 Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Net Income Per Ordinary Share The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 7,886,667 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the three and nine months ended September 30, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the three months ended For the nine months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 2,367,100 $ 575,267 $ 4,767,753 $ 1,193,668 Denominator: Weighted-average shares outstanding 23,660,000 5,750,000 23,053,333 5,730,769 Basic and diluted net income per share $ 0.10 $ 0.10 $ 0.21 $ 0.21 Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, (excluding the warrant liability) which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet primarily due to their short-term nature. Warrant Liability The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. The Company’s derivative instruments are recorded at fair value as of the IPO (January 8, 2021) and re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. As the warrants meet the definition of a derivative, the warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change. In accordance with ASC 825-10 “Financial Instruments”, the Company has concluded that a portion of the transaction costs which directly related to the IPO and the Private Placement, which were previously charged to shareholders’ equity, should be allocated to the Warrants based on their relative fair value against total proceeds, and recognized as transaction costs in the statement of operations. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2021
Initial Public Offering [Abstract]
Initial Public Offering	Note 4 — Initial Public Offering Pursuant to the IPO, the Company sold 23,000,000 Units, including 3,000,000 Units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or January 8, 2022 and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. (See Note 10) All of the 23,000,000 Class A ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s Amended and Restated Articles of Association. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Class A ordinary shares are subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated deficit.

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2021
Private Placement Disclosure [Abstract]
Private Placement	Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 660,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, for an aggregate purchase price of $6,600,000. A portion of the purchase price of the Private Placement Units were added to the proceeds from the IPO held in the Trust Account. Each Private Placement Unit was identical to the Units sold in the IPO, except for the Private Placement Warrants (see Note 10). If the Company does not complete its initial Business Combination by January 8, 2023, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of its public shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares In October 2020, the Company issued 5,750,000 Class B ordinary shares to the Sponsor for $25,000, or approximately $0.004 per share. Up to 750,000 shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriter’s over-allotment option is exercised. In connection with the underwriters’ full exercise of their over-allotment option on January 8, 2021, the 750,000 founder shares were no longer subject to forfeiture. The Sponsor has agreed not to transfer, assign or sell any of their founder shares until the earliest of (a) one year after the completion of an initial Business Combination and (b) subsequent to the initial Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of its public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Administrative Service Fee The Company has agreed, commencing on January 6, 2021, to pay the Sponsor or its affiliate a monthly fee of an aggregate of $10,000 for office space, administrative and shared personnel support services. This arrangement will terminate upon completion of a Business Combination or liquidation. During the three and nine months ended September 30, 2021, the Company recognized $30,000 and $88,387, respectively, in administrative service fee expense in the condensed statement of operations, which was included in due to related party on the unaudited condensed balance sheet as of September 30, 2021. Promissory Note — Related Party On October 5, 2020, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 to be used for a portion of the expenses of this IPO. This loan is non-interest bearing, unsecured and due at the earlier of September 30, 2021 or the closing of this IPO. The promissory note of $204,123 was repaid upon closing of the IPO and borrowings under this promissory note are no longer available. Due to R elated P art ies The Company owes $92,653 to related parties for the administrative service fee and other expense reimbursements. These amounts are non-interest bearing and are due on demand. Related Party Loans In order to finance transactions costs in connection with a Business Combination, post the Company’s IPO, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the working capital loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the working capital loans but no proceeds held in the Trust Account would be used to repay the working capital loans. Up to $1,500,000 of such loans may be convertible into Units at a price of $10.00 per Unit at the option of the lender at the time of the Business Combination. The Units would be identical to the Private Placement Units sold in the private placement. At September 30, 2021 and December 31, 2020, there were no amounts of working capital loans outstanding respectively.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Recurring Fair Value Measurements	Note 7 — Recurring Fair Value Measurements Investments Held in Trust Account As of September 30, 2021, the investments in the Company’s Trust Account consisted of $230,021,717 invested in U.S. Money Market funds. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. Fair values of the Company’s investments in the Trust Account are classified as Level 1 utilizing quoted prices (unadjusted) in active markets for identical assets. Warrant Liability At September 30, 2021, the Company’s warrant liability was valued at $4,670,007. Under the guidance in ASC 815-40 the warrants do not meet the criteria for equity treatment. As such, the warrants must be recorded on the balance sheet at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the warrant valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. Recurring Fair Value Measurements Since all of the Company’s permitted investments consist of U.S. Money Market funds, fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets. The Company’s Private Placement Warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the Private Placement Warrant liability is classified within Level 3 of the fair value hierarchy. The Company’s warrant liability for the Public Warrants is based on quoted prices (unadjusted) with less volume and transaction frequency than active markets. The fair value of the Public Warrant liability is classified within Level 2 of the fair value hierarchy. For the period ending September 30, 2021 the Public Warrants were reclassified from a Level 3 to a Level 2 classification. The following table presents fair value information as of September 30, 2021 of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Level 1 Level 2 Level 3 Assets Investments held in Trust Account—U.S. Money Market $ 230,021,717 $ — $ — Liabilities Public Warrants $ — $ 4,538,667 $ — Private Placement Warrants $ — $ — $ 131,340 Measurement On September 30, 2021 the Company valued the Public Warrants using traded prices and used a Monte Carlo simulation model to value the Private Placement Warrants. The key inputs into the Monte Carlo simulation model were as follows at September 30, 2021: Input September 30, Risk-free interest rate 1.12 % Expected term (years) 5.84 Expected volatility 10.6 % Exercise price $ 11.50 The following table provides a reconciliation of changes in fair value of the beginning and ending balances for our Warrants classified as Level 3: Fair value at December 31, 2020 $ — Initial value of warrant liability at January 8, 2021 11,910,336 Public Warrants reclassified to level 2 (1) (6,976,667 ) Change in fair value (4,802,329 ) Fair value at September 30, 2021 $ 131,340

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 — Commitments and Contingencies Registration Rights The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants which were issued in a private placement simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the prospectus to purchase up to an additional 3,000,000 units to cover over-allotments, if any, at $10.00 per Unit. Simultaneously with the closing of the IPO on January 8, 2021, the underwriters fully exercised the over-allotment option to purchase 3,000,000 Units, generating an aggregate of gross proceeds of $30,000,000. On January 8, 2021, the Company paid a fixed underwriting discount of $0.20 per Unit, $4,600,000 in the aggregate, in connection with the IPO. Additionally, the underwriters will be entitled to a deferred underwriting discount of 3.5%, or $8,050,000, of the gross proceeds of the IPO upon the completion of the Company’s initial Business Combination.

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit)	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Shareholders’ Equity (Deficit)	Note 9 — Shareholders’ Equity (Deficit) Preference Shares Class A Ordinary Shares Class B Ordinary Shares — Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, that holders of the Class B ordinary shares will have the right to appoint all of the Company’s directors prior to the initial Business Combination and holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like.

Warrants

Warrants	9 Months Ended
	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Warrants	Note 10 — Warrants At September 30, 2021 and December 31, 2020 there were 7,666,667 and 0 Public Warrants outstanding and 220,000 and 0 Private Placement Warrants outstanding, respectively. Each whole warrant entitles the holder to purchase one share of the Company’s Class A ordinary shares at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional shares of Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable on the later of January 8, 2022 or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A ordinary shares underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A ordinary shares upon exercise of a warrant unless Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A ordinary shares underlying such unit. Once the warrants become exercisable, the Company may call the warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and ● if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company send the notice of redemption to the warrant holders. The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. If the Company calls the warrants for redemption as described above, the Company will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the Company takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of shares of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the financial statements were issued. Other than as described in these financial statements, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Prospectus as filed with the SEC on January 7, 2021, which contains the audited financial statements and notes thereto. The interim results for the three and nine months ended September 30, 2021 and for the period September 24, 2020 through September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information
Offering Costs Associated with IPO	Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs amounted to $13,083,943 of which $658,022 were allocated to the warrant liabilities and expensed immediately and $12,425,941 were charged to temporary equity upon completion of the IPO and the exercise of the over-allotment option.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At September 30, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds from IPO $ 230,000,000 Less: Proceeds allocated to Public Warrants (11,577,774 ) Class A ordinary share issuance costs (12,425,941 ) Plus: Accretion of carrying value to redemption value 24,003,715 Contingently redeemable Class A ordinary shares $ 230,000,000
Income Taxes	Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.
Net Income Per Ordinary Share	Net Income Per Ordinary Share The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 7,886,667 potential ordinary shares for outstanding warrants to purchase the Company’s shares were excluded from diluted earnings per share for the three and nine months ended September 30, 2021 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the three months ended For the nine months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 2,367,100 $ 575,267 $ 4,767,753 $ 1,193,668 Denominator: Weighted-average shares outstanding 23,660,000 5,750,000 23,053,333 5,730,769 Basic and diluted net income per share $ 0.10 $ 0.10 $ 0.21 $ 0.21
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, (excluding the warrant liability) which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet primarily due to their short-term nature.
Warrant Liability	Warrant Liability The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. The Company’s derivative instruments are recorded at fair value as of the IPO (January 8, 2021) and re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument. As the warrants meet the definition of a derivative, the warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change. In accordance with ASC 825-10 “Financial Instruments”, the Company has concluded that a portion of the transaction costs which directly related to the IPO and the Private Placement, which were previously charged to shareholders’ equity, should be allocated to the Warrants based on their relative fair value against total proceeds, and recognized as transaction costs in the statement of operations.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt --debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging --Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’ Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows. The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
Risks and Uncertainties	Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Revision of Previously Issued_2

Revision of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2021
Revision Of Previously Issued Financial Statements [Abstract]
Schedule of revision on the company’s financial statements	As Previously Reported Revision Revised Balance Sheet as of January 8, 2021 Ordinary shares subject to possible redemption ($) $ 206,620,900 $ 23,379,100 $ 230,000,000 Class A ordinary shares, $0.0001 par value 300 (234 ) 66 Class B ordinary shares, $0.0001 par value 575 — 575 Additional Paid in Capital 5,669,811 (5,645,386 ) 24,425 Accumulated Deficit (670,682 ) (17,733,480 ) (18,404,162 ) Total Shareholders’ Equity (Deficit) $ 5,000,004 $ (23,379,100 ) $ (18,379,096 ) Number of shares subject to redemption 20,662,090 2,337,910 23,000,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of condensed balance sheets are reconciled	Gross proceeds from IPO $ 230,000,000 Less: Proceeds allocated to Public Warrants (11,577,774 ) Class A ordinary share issuance costs (12,425,941 ) Plus: Accretion of carrying value to redemption value 24,003,715 Contingently redeemable Class A ordinary shares $ 230,000,000
Schedule of basic and diluted net income per share	For the three months ended For the nine months ended Class A Class B Class A Class B Basic and diluted net income per share: Numerator: Allocation of net income $ 2,367,100 $ 575,267 $ 4,767,753 $ 1,193,668 Denominator: Weighted-average shares outstanding 23,660,000 5,750,000 23,053,333 5,730,769 Basic and diluted net income per share $ 0.10 $ 0.10 $ 0.21 $ 0.21

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of recurring fair value measurements	Level 1 Level 2 Level 3 Assets Investments held in Trust Account—U.S. Money Market $ 230,021,717 $ — $ — Liabilities Public Warrants $ — $ 4,538,667 $ — Private Placement Warrants $ — $ — $ 131,340
Schedule of fair value measurements	Input September 30, Risk-free interest rate 1.12 % Expected term (years) 5.84 Expected volatility 10.6 % Exercise price $ 11.50
Schedule of changes in the fair value of the warrant liability	Fair value at December 31, 2020 $ — Initial value of warrant liability at January 8, 2021 11,910,336 Public Warrants reclassified to level 2 (1) (6,976,667 ) Change in fair value (4,802,329 ) Fair value at September 30, 2021 $ 131,340

Organization and Business Ope_2

Organization and Business Operations (Details) - USD ($)	Jan. 08, 2021	Sep. 30, 2021	Dec. 31, 2020
Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)		$ 10
Gross proceeds		$ 230,000,000
Offering costs		13,083,943
Warrant liabilities		658,022
Expense of temporary equity		$ 12,425,941
Maturity term	185 days
Dissolution expenses	$ 100,000
Percentage of assets held in trust account		80.00%
Business combination of voting interest, percentage		50.00%
Redemption of public shares percentage		100.00%
Public per share (in Dollars per share)		$ 10
Repay outstanding balance		$ 575,714
Business Combination [Member]
Organization and Business Operations (Details) [Line Items]
Trust account per share (in Dollars per share)		$ 10
Sponsor [Member]
Organization and Business Operations (Details) [Line Items]
Price per share (in Dollars per share)		$ 10
IPO [Member]
Organization and Business Operations (Details) [Line Items]
Proposed public offering shares (in Shares)	23,000,000	23,000,000
Net offering proceeds	$ 230,000,000
Trust account per public share (in Dollars per share)	$ 10
Over-Allotment Option [Member]
Organization and Business Operations (Details) [Line Items]
Proposed public offering shares (in Shares)	3,000,000
Public per share (in Dollars per share)		$ 10
Private Placement [Member]
Organization and Business Operations (Details) [Line Items]
Proposed public offering shares (in Shares)		660,000
Gross proceeds		$ 6,600,000
Aggregate of warrants (in Shares)		220,000
Public per share (in Dollars per share)		$ 10
Class A Ordinary Shares [Member]
Organization and Business Operations (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)		0.0001	$ 0.0001
Ordinary share per share (in Dollars per share)		$ 11.5
Class A Ordinary Shares [Member] | Private Placement [Member]
Organization and Business Operations (Details) [Line Items]
Common stock, description		Each Unit consists of one share of Class A ordinary shares, and one-third redeemable warrant to purchase one share of Class A ordinary shares at a price of $11.50 per whole share, generating gross proceeds of $6,600,000, which is described in Note 4.
Class A Ordinary Shares [Member] | Private Placement Warrants [Member]
Organization and Business Operations (Details) [Line Items]
Aggregate of warrants (in Shares)		220,000

Revision of Previously Issued_3

Revision of Previously Issued Financial Statements (Details)	9 Months Ended
	Sep. 30, 2021USD ($)shares
Revision of Previously Issued Financial Statements (Details) [Line Items]
Net tangible assets	$ 5,000,001
Classes of shares (in Shares) | shares	2
Business Combination [Member]
Revision of Previously Issued Financial Statements (Details) [Line Items]
Shareholders equity	$ 5,000,000

Revision of Previously Issued_4

Revision of Previously Issued Financial Statements (Details) - Schedule of revision on the company’s financial statements	Jan. 08, 2021USD ($)shares
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares subject to possible redemption ($)	$ 206,620,900
Class A ordinary shares, $0.0001 par value	300
Class B ordinary shares, $0.0001 par value	575
Additional Paid in Capital	5,669,811
Accumulated Deficit	(670,682)
Total Shareholders’ Equity (Deficit)	$ 5,000,004
Number of shares subject to redemption (in Shares) | shares	20,662,090
Revision [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares subject to possible redemption ($)	$ 23,379,100
Class A ordinary shares, $0.0001 par value	(234)
Class B ordinary shares, $0.0001 par value
Additional Paid in Capital	(5,645,386)
Accumulated Deficit	(17,733,480)
Total Shareholders’ Equity (Deficit)	$ (23,379,100)
Number of shares subject to redemption (in Shares) | shares	2,337,910
Revised [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares subject to possible redemption ($)	$ 230,000,000
Class A ordinary shares, $0.0001 par value	66
Class B ordinary shares, $0.0001 par value	575
Additional Paid in Capital	24,425
Accumulated Deficit	(18,404,162)
Total Shareholders’ Equity (Deficit)	$ (18,379,096)
Number of shares subject to redemption (in Shares) | shares	23,000,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies (Details) [Line Items]
Offering costs	$ 13,083,943
Warrant liabilities	658,022
Expense of cequity	12,425,941
Warrants outstanding	$ 7,886,667
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Shares subject to possible redemption (in Shares)	23,000,000	0

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of condensed balance sheets are reconciled	9 Months Ended
	Sep. 30, 2021USD ($)
Schedule of condensed balance sheets are reconciled [Abstract]
Gross proceeds from IPO	$ 230,000,000
Less:
Proceeds allocated to Public Warrants	(11,577,774)
Class A ordinary share issuance costs	(12,425,941)
Plus:
Accretion of carrying value to redemption value	24,003,715
Contingently redeemable Class A ordinary shares	$ 230,000,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Class A [Member]
Numerator:
Allocation of net income (loss)	$ 2,367,100		$ 4,767,753
Denominator:
Weighted-average shares outstanding	23,660,000		23,053,333
Basic and diluted net income (loss) per share	$ 0.1		$ 0.21
Class B [Member]
Numerator:
Allocation of net income (loss)		$ 575,267		$ 1,193,668
Denominator:
Weighted-average shares outstanding		5,750,000		5,730,769
Basic and diluted net income (loss) per share		$ 0.1		$ 0.21

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares	Jan. 08, 2021	Sep. 30, 2021
Initial Public Offering (Details) [Line Items]
Price per unit (in Dollars per share)		$ 10
Business combination expire term, description		The warrants will become exercisable on the later of 30 days after the completion of the initial Business Combination or January 8, 2022 and will expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.
IPO [Member]
Initial Public Offering (Details) [Line Items]
Stock of sales	23,000,000	23,000,000
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Stock of sales	3,000,000
Underwriters option to purchase		3,000,000
Price per unit (in Dollars per share)		$ 10
Common stock price per share		10
Class A Ordinary Shares [Member]
Initial Public Offering (Details) [Line Items]
Common stock price per share		11.5
Class A Ordinary Shares [Member] | IPO [Member]
Initial Public Offering (Details) [Line Items]
Class A ordinary shares		23,000,000

Private Placement (Details)

Private Placement (Details) - Private Placement [Member]	9 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Private Placement (Details) [Line Items]
Purchased aggregate shares | shares	660,000
Sale of Stock, Price Per Share | $ / shares	$ 10
Aggregate amount of purchased value | $	$ 6,600,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jan. 08, 2021	Jan. 06, 2021	Oct. 05, 2020	Oct. 31, 2020	Sep. 30, 2021	Sep. 30, 2021
Related Party Transactions (Details) [Line Items]
Administrative fees expense		$ 10,000			$ 30,000	$ 88,387
Principal amount			$ 300,000
Due to related parties					92,653	92,653
Loan amount						$ 1,500,000
Business combination entity at price per unit (in Dollars per share)						$ 10
Over-Allotment Option [Member]
Related Party Transactions (Details) [Line Items]
Subject to forfeited shares (in Shares)	750,000			750,000
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Business combination, description						The Sponsor has agreed not to transfer, assign or sell any of their founder shares until the earliest of (a) one year after the completion of an initial Business Combination and (b) subsequent to the initial Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of its public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
IPO [Member]
Related Party Transactions (Details) [Line Items]
Promissory note amount					$ 204,123	$ 204,123
Class B Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares issued for services (in Shares)				5,750,000
Aggregate purchase price				$ 25,000
Price per share (in Dollars per share)				$ 0.004

Recurring Fair Value Measurem_3

Recurring Fair Value Measurements (Details)	Sep. 30, 2021USD ($)
Recurring Fair Value Measurements (Details) [Line Items]
Warrant liability value	$ 4,670,007
U.S. Money Market funds [Member]
Recurring Fair Value Measurements (Details) [Line Items]
Assets held in the trust account	$ 230,021,717

Recurring Fair Value Measurem_4

Recurring Fair Value Measurements (Details) - Schedule of recurring fair value measurements	Sep. 30, 2021USD ($)
Level 1 [Member]
Assets
Investments held in Trust Account—U.S. Money Market	$ 230,021,717
Liabilities
Public Warrants
Private Placement Warrants
Level 2 [Member]
Assets
Investments held in Trust Account—U.S. Money Market
Liabilities
Public Warrants	4,538,667
Private Placement Warrants
Level 3 [Member]
Assets
Investments held in Trust Account—U.S. Money Market
Liabilities
Public Warrants
Private Placement Warrants	$ 131,340

Recurring Fair Value Measurem_5

Recurring Fair Value Measurements (Details) - Schedule of fair value measurements	9 Months Ended
	Sep. 30, 2021$ / shares
Schedule of fair value measurements [Abstract]
Risk-free interest rate	1.12%
Expected term (years)	5 years 10 months 2 days
Expected volatility	10.60%
Exercise price (in Dollars per share)	$ 11.5

Recurring Fair Value Measurem_6

Recurring Fair Value Measurements (Details) - Schedule of changes in the fair value of the warrant liability	9 Months Ended
	Sep. 30, 2021USD ($)
Schedule of changes in the fair value of the warrant liability [Abstract]
Fair value
Initial value of warrant liability at January 8, 2021	11,910,336
Public Warrants reclassified to level 2	(6,976,667)
Change in fair value	(4,802,329)
Fair Value	$ 131,340

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Jan. 08, 2021	Sep. 30, 2021
Commitments and Contingencies (Details) [Line Items]
Underwriting discount per unit (in Dollars per share)	$ 0.2
Underwriting discount amount	$ 4,600,000
Deferred underwriting discount percentage	3.50%
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Number of additional units (in Shares)		3,000,000
Per share unit (in Dollars per share)		10
Purchase units (in Shares)	3,000,000
Gross proceeds	$ 30,000,000
IPO [Member]
Commitments and Contingencies (Details) [Line Items]
Gross proceeds	$ 8,050,000

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit) (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Shareholders’ Equity (Deficit) (Details) [Line Items]
Preference shares, shares authorized	5,000,000	5,000,000
Ordinary shares, shares issued		23,660,000
Ordinary shares, shares outstanding	0
Class A Ordinary Shares [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Ordinary shares, shares authorized	500,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares issued	23,660,000
Ordinary shares, shares outstanding		0
Common stock, shares subject to possible redemption	23,000,000	0
Class B Ordinary Shares [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Ordinary shares, shares authorized	50,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares issued	5,750,000	5,750,000
Ordinary shares, shares outstanding	5,750,000	5,750,000

Warrants (Details)

Warrants (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Warrants (Details) [Line Items]
Total equity proceeds, percentage	60.00%
Business combination market price per share	$ 9.2
Market value, percentage	115.00%
Warrant expiry term	5 years
Warrant [Member]
Warrants (Details) [Line Items]
Market value, percentage	180.00%
Redemption trigger price per share	$ 18
Public Warrants [Member]
Warrants (Details) [Line Items]
Public warrants outstanding	7,666,667	0
Private Placement Warrants [Member]
Warrants (Details) [Line Items]
Public warrants outstanding	220,000	0
Class A Ordinary Shares [Member]
Warrants (Details) [Line Items]
Warrant exercise price	$ 11.5
Redemption of warrant description	Once the warrants become exercisable, the Company may call the warrants for redemption:  ●in whole and not in part;     ● at a price of $0.01 per warrant;     ● upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and   ●if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company send the notice of redemption to the warrant holders.
Class A Ordinary Shares [Member] | Business Combination [Member]
Warrants (Details) [Line Items]
Business combination issue price	$ 9.2